Abstract Purpose of Review To highlight the added benefits of approved and upcoming,
centrally-acting, anti-obesity drugs, focusing not only on the most common metabolic and …

Obesity is an epidemic and a public health threat. Medical weight management remains one
of the options for the treatment of excess weight and recent advances have revolutionized …

Obesity is a chronic, recurring, progressive disease and a major public health problem
associated with several other diseases that lead to disability, morbidity, and mortality. The …

Introduction: Obesity is a rapidly increasing global health problem. The rates of obesity have
tripled over the past three decades and are predicted to rise even further. The need for safe …

Obesity is a metabolic dysfunction associated with a wide range of chronic illnesses that
cause significant increases in comorbidity and mortality. According to the World Health …

Obesity is one of the greatest public health challenges of the twenty-first century. The World
Health Organization (WHO) reports that in 2005 approximately 1.6 billion adults were …

Introduction The field of obesity medicine has evolved over the past several years. With
greater understanding of its pathophysiology, obesity is regarded more as a chronic disease …

Obesity is a chronic medical condition that is expected to become an indirect but leading
cause of mortality and morbidity. Obesity results in type 2 diabetes mellitus, insulin …

Obesity is a major correlate of cardiovascular disease. Weight loss improves cardiovascular
risk factors and has the potential to improve outcomes. Two drugs, phentermine plus …

Introduction Pharmacotherapy is a useful adjunct when patients with obesity are unable to
achieve adequate benefit from lifestyle interventions. Areas covered This review covers the …